You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Key takeaways: Lack of diversity results in insufficient data regarding treatment safety and efficacy. African American and Hispanic patients are significantly underrepresented in clinical trials for multiple myeloma.
